Skip to main content
Erschienen in: Digestive Diseases and Sciences 7/2012

01.07.2012 | Original Article

Impedance pH Confirms the Relationship Between GERD and BMI

verfasst von: Nasser Hajar, Donald O. Castell, Hassan Ghomrawi, Richard Rackett, Amine Hila

Erschienen in: Digestive Diseases and Sciences | Ausgabe 7/2012

Einloggen, um Zugang zu erhalten

Abstract

Background

During the last 20 years the prevalence of both gastroesophageal reflux disease (GERD) and obesity has been increasing in the United States. The pathophysiology of GERD is multifactorial and its relationship with obesity is still not well understood.

Aim

To evaluate the association between BMI and GERD as detected by multichannel intraluminal impedance-pH (MII-pH) monitoring.

Methods

Retrospective review of 122 consecutive MII-pH studies of adult patients while on PPI therapy. Patients were divided into normal (BMI < 25), overweight (BMI ≥ 25 and <30) and obese (BMI ≥ 30). Reflux episodes were classified as acid reflux (AR), nonacid reflux (NAR), and total number of reflux episodes, as detected by MII-pH. We evaluated the symptoms associated with reflux by using the symptom index (SI). We also assessed the number of reflux episodes during recumbency and compared them in the different BMI groups.

Results

The total number of reflux episodes and NAR episodes increased significantly as BMI increased. There was no significant difference between groups in AR. Similarly, during recumbency, total number of reflux episodes increased significantly when BMI increased. For symptoms associated with reflux, SI was more likely to be positive in the obese group.

Conclusions

This study shows a clear association between increased reflux as detected by MII-pH and higher BMI. Obesity not only increases the likelihood of reflux events, as shown in previous studies, but also makes it more likely that symptoms reported during MII-pH studies are actually due to MII detected reflux.
Literatur
1.
Zurück zum Zitat Mokdad AH, Serdula MK, Dietz WH, et al. The spread of the obesity epidemic in the United States, 1991–1998. JAMA. 1999;282:1519–1522.PubMedCrossRef Mokdad AH, Serdula MK, Dietz WH, et al. The spread of the obesity epidemic in the United States, 1991–1998. JAMA. 1999;282:1519–1522.PubMedCrossRef
2.
Zurück zum Zitat Flegal KM, Carroll MD, Ogden CL, et al. Prevalence and trends in obesity among US adults, 1999–2000. JAMA. 2002;288:1723–1727.PubMedCrossRef Flegal KM, Carroll MD, Ogden CL, et al. Prevalence and trends in obesity among US adults, 1999–2000. JAMA. 2002;288:1723–1727.PubMedCrossRef
3.
Zurück zum Zitat Ogden CL, Carroll MD, McDowell, et al. Obesity among adults in the United States—no statistically significant change since 2003–2004. NCHS Data Brief. 2007;1:1–8. Ogden CL, Carroll MD, McDowell, et al. Obesity among adults in the United States—no statistically significant change since 2003–2004. NCHS Data Brief. 2007;1:1–8.
4.
Zurück zum Zitat Blumberg SJ, Luke JV, Davidson G, et al. Wireless substitution: state-level estimates from the National Health Interview Survey, January-December 2007. Natl Health Stat Report. 2009;11:16. Blumberg SJ, Luke JV, Davidson G, et al. Wireless substitution: state-level estimates from the National Health Interview Survey, January-December 2007. Natl Health Stat Report. 2009;11:16.
5.
Zurück zum Zitat El-Serag HB, Petersen NJ, Carter J, et al. Gastroesophageal reflux among different racial groups in the United States. Gastroenterology. 2004;126:1692–1699.PubMedCrossRef El-Serag HB, Petersen NJ, Carter J, et al. Gastroesophageal reflux among different racial groups in the United States. Gastroenterology. 2004;126:1692–1699.PubMedCrossRef
6.
Zurück zum Zitat Lambert R. In search of reliability in the description of gastroesophageal reflux disease (GERD). Esophagus. 2008;5:5–9.CrossRef Lambert R. In search of reliability in the description of gastroesophageal reflux disease (GERD). Esophagus. 2008;5:5–9.CrossRef
7.
Zurück zum Zitat El Serag HB. The association between obesity and GERD: a review of the epidemiological evidence. Dig Dis Sci. 2008;53:2307–2312.PubMedCrossRef El Serag HB. The association between obesity and GERD: a review of the epidemiological evidence. Dig Dis Sci. 2008;53:2307–2312.PubMedCrossRef
8.
Zurück zum Zitat Crowell MD, Bradley A, Hansel S, et al. Obesity is associated with increased 48-h esophageal acid exposure in patients with symptomatic gastroesophageal reflux. Am J Gastroenterol. 2009;104:553–559.PubMedCrossRef Crowell MD, Bradley A, Hansel S, et al. Obesity is associated with increased 48-h esophageal acid exposure in patients with symptomatic gastroesophageal reflux. Am J Gastroenterol. 2009;104:553–559.PubMedCrossRef
9.
Zurück zum Zitat Ayazi S, Hagen JA, Chan LS, et al. Obesity and gastroesophageal reflux: quantifying the association between body mass index, esophageal acid exposure, and lower esophageal sphincter status in a large series of patients with reflux symptoms. J Gastrointest Surg. 2009;13:1440–1447.PubMedCrossRef Ayazi S, Hagen JA, Chan LS, et al. Obesity and gastroesophageal reflux: quantifying the association between body mass index, esophageal acid exposure, and lower esophageal sphincter status in a large series of patients with reflux symptoms. J Gastrointest Surg. 2009;13:1440–1447.PubMedCrossRef
10.
Zurück zum Zitat Sifrim D, Castell D, Dent J, et al. Gastro-oesophageal reflux monitoring: review and consensus report on detection and definitions of acid, non-acid, and gas reflux. Gut. 2004;53:1024–1031.PubMedCrossRef Sifrim D, Castell D, Dent J, et al. Gastro-oesophageal reflux monitoring: review and consensus report on detection and definitions of acid, non-acid, and gas reflux. Gut. 2004;53:1024–1031.PubMedCrossRef
11.
Zurück zum Zitat Hirano I, Richter JE, et al. ACG practice guidelines: esophageal reflux testing. Am J Gastroenterol. 2007;102:668–685.PubMedCrossRef Hirano I, Richter JE, et al. ACG practice guidelines: esophageal reflux testing. Am J Gastroenterol. 2007;102:668–685.PubMedCrossRef
12.
Zurück zum Zitat National Institutes of Health. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults—the evidence report. Obes Res. 1998;6:51S–209S. National Institutes of Health. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults—the evidence report. Obes Res. 1998;6:51S–209S.
13.
Zurück zum Zitat Wiener GJ, Richter JE, Copper JB, et al. The symptom index: a clinically important parameter of ambulatory 24-hour esophageal pH monitoring. Am J Gastroenterol. 1988;83:358–361.PubMed Wiener GJ, Richter JE, Copper JB, et al. The symptom index: a clinically important parameter of ambulatory 24-hour esophageal pH monitoring. Am J Gastroenterol. 1988;83:358–361.PubMed
14.
Zurück zum Zitat Singh S, Richter JE, Bradley LA, et al. The symptom index. Differential usefulness in suspected acid-related complaints of heartburn and chest pain. Dig Dis Sci. 1993;38:1402–1408.PubMedCrossRef Singh S, Richter JE, Bradley LA, et al. The symptom index. Differential usefulness in suspected acid-related complaints of heartburn and chest pain. Dig Dis Sci. 1993;38:1402–1408.PubMedCrossRef
15.
Zurück zum Zitat Mainie I, Tutuian R, Shay S, et al. Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicenter study using combined ambulatory impedance-pH monitoring. Gut. 2006;55:1398–1402.PubMedCrossRef Mainie I, Tutuian R, Shay S, et al. Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicenter study using combined ambulatory impedance-pH monitoring. Gut. 2006;55:1398–1402.PubMedCrossRef
16.
Zurück zum Zitat Kuo B, Castell DO. Optimal dosing of omeprazole 40 mg daily: effects on gastric and esophageal pH and serum gastrin in healthy controls. Am J Gastroenterol. 1996;91:1532–1538.PubMed Kuo B, Castell DO. Optimal dosing of omeprazole 40 mg daily: effects on gastric and esophageal pH and serum gastrin in healthy controls. Am J Gastroenterol. 1996;91:1532–1538.PubMed
17.
Zurück zum Zitat World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO convention, Geneva, 1999. World Health Organ Tech Rep Ser. 2000;894:1–253. World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO convention, Geneva, 1999. World Health Organ Tech Rep Ser. 2000;894:1–253.
18.
Zurück zum Zitat Connor J, Richter J. Increasing yield also increases false positives and best serves to exclude GERD. Am J Gastroenterol. 2006;101:460–463.PubMedCrossRef Connor J, Richter J. Increasing yield also increases false positives and best serves to exclude GERD. Am J Gastroenterol. 2006;101:460–463.PubMedCrossRef
19.
Zurück zum Zitat Pandolfino J. The relationship between obesity and GERD: “big or overblown”. Am J Gastroenterol. 2008;103:1355–1357. Pandolfino J. The relationship between obesity and GERD: “big or overblown”. Am J Gastroenterol. 2008;103:1355–1357.
20.
Zurück zum Zitat Wu JC, Mui LM, Cheung CM, et al. Obesity is associated with increased transient lower esophageal sphincter relaxation. Gastroenterology. 2007;132:883–889.PubMedCrossRef Wu JC, Mui LM, Cheung CM, et al. Obesity is associated with increased transient lower esophageal sphincter relaxation. Gastroenterology. 2007;132:883–889.PubMedCrossRef
21.
Zurück zum Zitat Pandolfino JE, El Serag HB, Zhang Q, et al. Obesity: a challenge to esophagogastric junction integrity. Gastroenterology. 2006;130:639–649.PubMedCrossRef Pandolfino JE, El Serag HB, Zhang Q, et al. Obesity: a challenge to esophagogastric junction integrity. Gastroenterology. 2006;130:639–649.PubMedCrossRef
Metadaten
Titel
Impedance pH Confirms the Relationship Between GERD and BMI
verfasst von
Nasser Hajar
Donald O. Castell
Hassan Ghomrawi
Richard Rackett
Amine Hila
Publikationsdatum
01.07.2012
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 7/2012
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-012-2131-6

Weitere Artikel der Ausgabe 7/2012

Digestive Diseases and Sciences 7/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.